
The U.S. Food and Drug Administration on Saturday approved Johnson & Johnson’s single-shot coronavirus vaccine for emergency use after its advisory panel unanimously backed the vaccine a day earlier. Adding a third vaccine to the country’s arsenal will help boost the nation’s limited supply of the two authorized shots, from Pfizer and Moderna. The first… read on > read on >